Dr Lamanna on the Use of Novel Agents Following Progression in CLL

Nicole Lamanna, MD, discusses how the use of novel agents could address resistance associated with current treatment options for patients with chronic lymphocytic leukemia.

Related Keywords

Nicole Lamanna ,Hematology Oncology Division ,Columbia University ,National Comprehensive Cancer Network Guidelines ,Herbert Irving Comprehensive Cancer Center ,Hematologic Malignancies Section ,Oncology Division ,National Comprehensive Cancer Network ,Columbia University Herbert Irving Comprehensive Cancer Center ,Onclive Tv ,Chronic Lymphocytic Leukemia ,